Robert Sun

发表

RhI-catalyzed C-C bond activation: seven-membered ring synthesis by a [6+1] carbonylative ring-expansion reaction of allenylcyclobutanes.

P. Wender, N. Deschamps, Robert Sun, 2006, Angewandte Chemie.

Function-oriented synthesis: studies aimed at the synthesis and mode of action of 1alpha-alkyldaphnane analogues.

P. Wender, J. Kowalski, Noel D'angelo, 2007, Organic letters.

Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.

A. D'arcy, M. Mogi, C. Wiesmann, 2020, ACS medicinal chemistry letters.

Toward the ideal synthesis. New transition metal-catalyzed reactions inspired by novel medicinal leads

F. Gosselin, T. Williams, P. Wender, 2002 .

Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).

D. Curtis, M. Hild, Yiping Shen, 2018, Journal of medicinal chemistry.

Transition Metal-Catalyzed (6+2) Cycloadditions of 2-Vinylcyclobutanones and Alkenes: A New Reaction for the Synthesis of Eight-Membered Rings

A. Corrêa, P. Wender, Robert Sun, 2000 .

Rh(I)-catalyzed cleavage of unactivated CO bonds Carbonylative rearrangement reactions of allenyl ethers to 2-carboalkoxy-1,3-dienes

P. Wender, N. Deschamps, Robert Sun, 2005 .

MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology.

K. Cox, P. Kirschmeier, R. Doll, 2018, ACS medicinal chemistry letters.

Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology.

P. Kirschmeier, R. Doll, W. Windsor, 2018, Bioorganic & medicinal chemistry letters.